Looking back and looking forward to a new chapter of common development

Release time:

2024-01-16


On January 16, 2024, Jiangsu Qi07 Natural Pharmaceutical Co., Ltd. held a three-day year-end summary and annual planning conference with the theme of "win-win 2024" in the conference hall.

On January 16, 2024, Jiangsu Qi07 Natural Pharmaceutical Co., Ltd. held a three-day year-end summary and annual planning conference with the theme of "win-win 2024" in the conference hall. The purpose of this conference is to summarize 2023 and to plan for 2024, and to clarify the overall business objectives.

Participating in this meeting were Chairman Geng Tongquan, General Manager Jiang Shurong of the company, Deputy General Manager Shao Xiang of the Marketing Center and all colleagues of the Marketing Center.

At the beginning of the meeting, under the leadership of Shao Xiang, deputy general manager of the marketing center, we reviewed the sales performance and completion in 2023, summarized the highlights and shortcomings in the past year, put forward improvement ideas and placed high hopes on 2024.

Subsequently, Chairman Geng Tongquan delivered a speech, sharing the company's key issues in the past year, putting forward new requirements for the marketing center team, and accelerating the implementation of the dual-driven development strategy of product marketing and project marketing.

Then, General Manager Jiang Shurong interpreted the "2024 Marketing Plan" and insisted on taking "self-operated sales of regular proprietary Chinese medicine products", "general agent sales of large health products" and "landing promotion of traditional Chinese medicine pain-relieving characteristic therapy projects" as the marketing direction. According to the company's "troika" overall development strategy, the goal is to create three "4 million bottles (boxes)" product groups. The follow-up will strengthen promotion training, resident promotion and consumer experience activities, and further implement the three-three-three project based on [Zhenjiang Plaster].

Finally, the regional directors reported on the 2024 work plan, showed the work deployment, variety promotion and customers in the region, and shared the market access, development and marketing activities of Zhenjiang plaster.

This year-end conference was successfully concluded. In the future, under the leadership of Chairman Geng Tongquan, 707 Natural Pharmaceuticals will adhere to the concept of "inheriting the essence, keeping integrity and innovation", with the goal of caring for human health, and work hand in hand with many like-minded partners!